VALERIE MAGRINO: Open Payments
NPI 1427501758 · FREEHOLD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,365 in 147 payments from 11 companies in 2025. Trend: 2023 $1,661 · 2024 $1,983 · 2025 $2,365
Food & beverage: $2,365
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 20 | $618 |
| ABBVIE INC. | 51 | $499 |
| Otsuka America Pharmaceutical, Inc. | 21 | $343 |
| Axsome Therapeutics, Inc. | 14 | $309 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $176 |
| Lundbeck LLC | 14 | $159 |
| Teva Pharmaceuticals USA, Inc. | 9 | $157 |
| Alkermes, Inc. | 3 | $55 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
| Collegium Pharmaceutical, Inc. | 1 | $16 |
Products named: CAPLYTA, VRAYLAR, REXULTI, Auvelity, TRINTELLIX, AUSTEDO XR, LYBALVI, ARISTADA.
Industry payments across NJ — which companies pay providers there.
